nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—CYP3A4—Pilocarpine—glaucoma	0.0825	0.235	CbGbCtD
Etonogestrel—CYP3A4—Brinzolamide—glaucoma	0.0648	0.185	CbGbCtD
Etonogestrel—CYP3A4—Dorzolamide—glaucoma	0.0625	0.178	CbGbCtD
Etonogestrel—CYP3A4—Methazolamide—glaucoma	0.0557	0.159	CbGbCtD
Etonogestrel—CYP3A4—Acetazolamide—glaucoma	0.0446	0.127	CbGbCtD
Etonogestrel—CYP3A4—Clonidine—glaucoma	0.0403	0.115	CbGbCtD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—POU4F2—glaucoma	0.00371	0.0997	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—POU4F2—glaucoma	0.00218	0.0585	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—POU4F1—glaucoma	0.00203	0.0546	CbGpPWpGaD
Etonogestrel—ESR1—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.00152	0.0407	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—POU4F1—glaucoma	0.00119	0.0321	CbGpPWpGaD
Etonogestrel—PGR—Ovarian Infertility Genes—CCND2—glaucoma	0.00118	0.0317	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—RPTOR—glaucoma	0.00111	0.0298	CbGpPWpGaD
Etonogestrel—ESR1—Signaling events mediated by HDAC Class II—HDAC9—glaucoma	0.00101	0.0271	CbGpPWpGaD
Etonogestrel—PGR—Nuclear Receptors—NR3C1—glaucoma	0.00081	0.0218	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PITX2—glaucoma	0.000773	0.0207	CbGpPWpGaD
Etonogestrel—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000663	0.0178	CbGpPWpGaD
Etonogestrel—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000649	0.0174	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—SOD1—glaucoma	0.000644	0.0173	CbGpPWpGaD
Etonogestrel—PGR—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.00064	0.0172	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000552	0.0148	CbGpPWpGaD
Etonogestrel—PGR—Ovarian Infertility Genes—CDKN1B—glaucoma	0.000537	0.0144	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—TGFB2—glaucoma	0.000532	0.0143	CbGpPWpGaD
Etonogestrel—PGR—Cellular roles of Anthrax toxin—TNF—glaucoma	0.000516	0.0139	CbGpPWpGaD
Etonogestrel—Visual impairment—Betaxolol—glaucoma	0.000512	0.000836	CcSEcCtD
Etonogestrel—Insomnia—Brinzolamide—glaucoma	0.000511	0.000835	CcSEcCtD
Etonogestrel—Somnolence—Dorzolamide—glaucoma	0.000511	0.000834	CcSEcCtD
Etonogestrel—Muscle spasms—Clonidine—glaucoma	0.000511	0.000834	CcSEcCtD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.00051	0.0137	CbGpPWpGaD
Etonogestrel—ESR1—FOXA1 transcription factor network—SOD1—glaucoma	0.00051	0.0137	CbGpPWpGaD
Etonogestrel—Paraesthesia—Brinzolamide—glaucoma	0.000507	0.000829	CcSEcCtD
Etonogestrel—Dysuria—Timolol—glaucoma	0.000507	0.000828	CcSEcCtD
Etonogestrel—Dyspepsia—Dorzolamide—glaucoma	0.000506	0.000826	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Timolol—glaucoma	0.000504	0.000823	CcSEcCtD
Etonogestrel—Dyspepsia—Travoprost—glaucoma	0.000504	0.000823	CcSEcCtD
Etonogestrel—Asthenia—Apraclonidine—glaucoma	0.000503	0.000821	CcSEcCtD
Etonogestrel—Somnolence—Brinzolamide—glaucoma	0.000502	0.00082	CcSEcCtD
Etonogestrel—Decreased appetite—Dorzolamide—glaucoma	0.0005	0.000816	CcSEcCtD
Etonogestrel—Urticaria—Acetazolamide—glaucoma	0.000498	0.000814	CcSEcCtD
Etonogestrel—Dyspepsia—Brinzolamide—glaucoma	0.000497	0.000812	CcSEcCtD
Etonogestrel—Eye disorder—Betaxolol—glaucoma	0.000497	0.000811	CcSEcCtD
Etonogestrel—Pruritus—Apraclonidine—glaucoma	0.000496	0.00081	CcSEcCtD
Etonogestrel—Body temperature increased—Acetazolamide—glaucoma	0.000496	0.00081	CcSEcCtD
Etonogestrel—Fatigue—Dorzolamide—glaucoma	0.000495	0.000809	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000495	0.000808	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Travoprost—glaucoma	0.000494	0.000807	CcSEcCtD
Etonogestrel—Fatigue—Travoprost—glaucoma	0.000493	0.000806	CcSEcCtD
Etonogestrel—Ill-defined disorder—Clonidine—glaucoma	0.000493	0.000805	CcSEcCtD
Etonogestrel—Pain—Dorzolamide—glaucoma	0.000491	0.000803	CcSEcCtD
Etonogestrel—Insomnia—Pilocarpine—glaucoma	0.000491	0.000802	CcSEcCtD
Etonogestrel—Decreased appetite—Brinzolamide—glaucoma	0.000491	0.000802	CcSEcCtD
Etonogestrel—Weight decreased—Timolol—glaucoma	0.000491	0.000801	CcSEcCtD
Etonogestrel—Constipation—Travoprost—glaucoma	0.000489	0.000799	CcSEcCtD
Etonogestrel—Pain—Travoprost—glaucoma	0.000489	0.000799	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000488	0.000797	CcSEcCtD
Etonogestrel—Paraesthesia—Pilocarpine—glaucoma	0.000488	0.000796	CcSEcCtD
Etonogestrel—Asthenia—Bimatoprost—glaucoma	0.000488	0.000796	CcSEcCtD
Etonogestrel—Fatigue—Brinzolamide—glaucoma	0.000487	0.000796	CcSEcCtD
Etonogestrel—Angioedema—Clonidine—glaucoma	0.000486	0.000793	CcSEcCtD
Etonogestrel—Pain—Brinzolamide—glaucoma	0.000483	0.000789	CcSEcCtD
Etonogestrel—Somnolence—Pilocarpine—glaucoma	0.000483	0.000788	CcSEcCtD
Etonogestrel—Depression—Timolol—glaucoma	0.000482	0.000788	CcSEcCtD
Etonogestrel—Angiopathy—Betaxolol—glaucoma	0.000482	0.000787	CcSEcCtD
Etonogestrel—Pruritus—Bimatoprost—glaucoma	0.000481	0.000785	CcSEcCtD
Etonogestrel—Immune system disorder—Betaxolol—glaucoma	0.00048	0.000784	CcSEcCtD
Etonogestrel—Diarrhoea—Apraclonidine—glaucoma	0.00048	0.000783	CcSEcCtD
Etonogestrel—Malaise—Clonidine—glaucoma	0.000479	0.000783	CcSEcCtD
Etonogestrel—Dyspepsia—Pilocarpine—glaucoma	0.000478	0.000781	CcSEcCtD
Etonogestrel—ESR1—Signaling events mediated by HDAC Class II—NR3C1—glaucoma	0.000476	0.0128	CbGpPWpGaD
Etonogestrel—ESR1—Nuclear Receptors—NR3C1—glaucoma	0.000476	0.0128	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Dorzolamide—glaucoma	0.000474	0.000773	CcSEcCtD
Etonogestrel—Decreased appetite—Pilocarpine—glaucoma	0.000472	0.000771	CcSEcCtD
Etonogestrel—Feeling abnormal—Travoprost—glaucoma	0.000472	0.00077	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Dorzolamide—glaucoma	0.00047	0.000768	CcSEcCtD
Etonogestrel—Alopecia—Betaxolol—glaucoma	0.00047	0.000767	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000469	0.000766	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Travoprost—glaucoma	0.000468	0.000764	CcSEcCtD
Etonogestrel—Feeling abnormal—Brinzolamide—glaucoma	0.000466	0.00076	CcSEcCtD
Etonogestrel—Mental disorder—Betaxolol—glaucoma	0.000466	0.00076	CcSEcCtD
Etonogestrel—Pain—Pilocarpine—glaucoma	0.000464	0.000758	CcSEcCtD
Etonogestrel—Constipation—Pilocarpine—glaucoma	0.000464	0.000758	CcSEcCtD
Etonogestrel—Cough—Clonidine—glaucoma	0.000464	0.000757	CcSEcCtD
Etonogestrel—Dizziness—Apraclonidine—glaucoma	0.000464	0.000757	CcSEcCtD
Etonogestrel—Erythema—Betaxolol—glaucoma	0.000463	0.000756	CcSEcCtD
Etonogestrel—Malnutrition—Betaxolol—glaucoma	0.000463	0.000756	CcSEcCtD
Etonogestrel—Urticaria—Dorzolamide—glaucoma	0.000457	0.000746	CcSEcCtD
Etonogestrel—Abdominal pain—Dorzolamide—glaucoma	0.000454	0.000742	CcSEcCtD
Etonogestrel—Body temperature increased—Dorzolamide—glaucoma	0.000454	0.000742	CcSEcCtD
Etonogestrel—Tension—Betaxolol—glaucoma	0.000454	0.000741	CcSEcCtD
Etonogestrel—Sinusitis—Timolol—glaucoma	0.000454	0.000741	CcSEcCtD
Etonogestrel—Arthralgia—Clonidine—glaucoma	0.000452	0.000739	CcSEcCtD
Etonogestrel—Abdominal pain—Travoprost—glaucoma	0.000452	0.000739	CcSEcCtD
Etonogestrel—Anxiety—Clonidine—glaucoma	0.000451	0.000736	CcSEcCtD
Etonogestrel—Asthenia—Acetazolamide—glaucoma	0.00045	0.000735	CcSEcCtD
Etonogestrel—Dizziness—Bimatoprost—glaucoma	0.000449	0.000734	CcSEcCtD
Etonogestrel—Nervousness—Betaxolol—glaucoma	0.000449	0.000734	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000449	0.000734	CcSEcCtD
Etonogestrel—Urticaria—Brinzolamide—glaucoma	0.000449	0.000733	CcSEcCtD
Etonogestrel—Feeling abnormal—Pilocarpine—glaucoma	0.000448	0.000731	CcSEcCtD
Etonogestrel—Discomfort—Clonidine—glaucoma	0.000447	0.00073	CcSEcCtD
Etonogestrel—Vomiting—Apraclonidine—glaucoma	0.000446	0.000728	CcSEcCtD
Etonogestrel—Muscle spasms—Betaxolol—glaucoma	0.000445	0.000726	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Pilocarpine—glaucoma	0.000444	0.000725	CcSEcCtD
Etonogestrel—Hypersensitivity—Brimonidine—glaucoma	0.000443	0.000724	CcSEcCtD
Etonogestrel—Dermatitis—Apraclonidine—glaucoma	0.000442	0.000721	CcSEcCtD
Etonogestrel—Headache—Apraclonidine—glaucoma	0.000439	0.000717	CcSEcCtD
Etonogestrel—Rhinitis—Timolol—glaucoma	0.000435	0.000711	CcSEcCtD
Etonogestrel—Oedema—Clonidine—glaucoma	0.000434	0.000708	CcSEcCtD
Etonogestrel—Asthenia—Brimonidine—glaucoma	0.000432	0.000705	CcSEcCtD
Etonogestrel—Infection—Clonidine—glaucoma	0.000431	0.000704	CcSEcCtD
Etonogestrel—Body temperature increased—Pilocarpine—glaucoma	0.000429	0.000701	CcSEcCtD
Etonogestrel—Abdominal pain—Pilocarpine—glaucoma	0.000429	0.000701	CcSEcCtD
Etonogestrel—Ill-defined disorder—Betaxolol—glaucoma	0.000429	0.000701	CcSEcCtD
Etonogestrel—Diarrhoea—Acetazolamide—glaucoma	0.000429	0.000701	CcSEcCtD
Etonogestrel—Rash—Bimatoprost—glaucoma	0.000429	0.0007	CcSEcCtD
Etonogestrel—Dermatitis—Bimatoprost—glaucoma	0.000428	0.000699	CcSEcCtD
Etonogestrel—Connective tissue disorder—Timolol—glaucoma	0.000427	0.000697	CcSEcCtD
Etonogestrel—Pruritus—Brimonidine—glaucoma	0.000426	0.000695	CcSEcCtD
Etonogestrel—Headache—Bimatoprost—glaucoma	0.000426	0.000695	CcSEcCtD
Etonogestrel—Nervous system disorder—Clonidine—glaucoma	0.000425	0.000695	CcSEcCtD
Etonogestrel—Hypersensitivity—Dorzolamide—glaucoma	0.000423	0.000692	CcSEcCtD
Etonogestrel—Hypersensitivity—Travoprost—glaucoma	0.000422	0.000689	CcSEcCtD
Etonogestrel—Skin disorder—Clonidine—glaucoma	0.000421	0.000688	CcSEcCtD
Etonogestrel—Visual impairment—Timolol—glaucoma	0.000418	0.000683	CcSEcCtD
Etonogestrel—Malaise—Betaxolol—glaucoma	0.000417	0.000681	CcSEcCtD
Etonogestrel—Nausea—Apraclonidine—glaucoma	0.000416	0.00068	CcSEcCtD
Etonogestrel—Hypersensitivity—Brinzolamide—glaucoma	0.000416	0.00068	CcSEcCtD
Etonogestrel—Dizziness—Acetazolamide—glaucoma	0.000415	0.000677	CcSEcCtD
Etonogestrel—Anorexia—Clonidine—glaucoma	0.000413	0.000675	CcSEcCtD
Etonogestrel—Asthenia—Dorzolamide—glaucoma	0.000412	0.000673	CcSEcCtD
Etonogestrel—Asthenia—Travoprost—glaucoma	0.000411	0.000671	CcSEcCtD
Etonogestrel—Pruritus—Dorzolamide—glaucoma	0.000407	0.000664	CcSEcCtD
Etonogestrel—Eye disorder—Timolol—glaucoma	0.000406	0.000663	CcSEcCtD
Etonogestrel—Asthenia—Brinzolamide—glaucoma	0.000405	0.000662	CcSEcCtD
Etonogestrel—Pruritus—Travoprost—glaucoma	0.000405	0.000661	CcSEcCtD
Etonogestrel—Cough—Betaxolol—glaucoma	0.000404	0.000659	CcSEcCtD
Etonogestrel—Nausea—Bimatoprost—glaucoma	0.000404	0.000659	CcSEcCtD
Etonogestrel—Hypersensitivity—Pilocarpine—glaucoma	0.0004	0.000653	CcSEcCtD
Etonogestrel—Pruritus—Brinzolamide—glaucoma	0.0004	0.000653	CcSEcCtD
Etonogestrel—Vomiting—Acetazolamide—glaucoma	0.000399	0.000651	CcSEcCtD
Etonogestrel—Dizziness—Brimonidine—glaucoma	0.000398	0.00065	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Clonidine—glaucoma	0.000395	0.000645	CcSEcCtD
Etonogestrel—Angiopathy—Timolol—glaucoma	0.000394	0.000643	CcSEcCtD
Etonogestrel—Myalgia—Betaxolol—glaucoma	0.000394	0.000643	CcSEcCtD
Etonogestrel—Arthralgia—Betaxolol—glaucoma	0.000394	0.000643	CcSEcCtD
Etonogestrel—Diarrhoea—Dorzolamide—glaucoma	0.000393	0.000642	CcSEcCtD
Etonogestrel—Headache—Acetazolamide—glaucoma	0.000393	0.000642	CcSEcCtD
Etonogestrel—Anxiety—Betaxolol—glaucoma	0.000392	0.000641	CcSEcCtD
Etonogestrel—Insomnia—Clonidine—glaucoma	0.000392	0.000641	CcSEcCtD
Etonogestrel—Immune system disorder—Timolol—glaucoma	0.000392	0.00064	CcSEcCtD
Etonogestrel—Diarrhoea—Travoprost—glaucoma	0.000392	0.000639	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000391	0.000639	CcSEcCtD
Etonogestrel—Asthenia—Pilocarpine—glaucoma	0.00039	0.000636	CcSEcCtD
Etonogestrel—Paraesthesia—Clonidine—glaucoma	0.000389	0.000636	CcSEcCtD
Etonogestrel—Discomfort—Betaxolol—glaucoma	0.000389	0.000636	CcSEcCtD
Etonogestrel—Diarrhoea—Brinzolamide—glaucoma	0.000387	0.000631	CcSEcCtD
Etonogestrel—Somnolence—Clonidine—glaucoma	0.000386	0.00063	CcSEcCtD
Etonogestrel—Pruritus—Pilocarpine—glaucoma	0.000384	0.000627	CcSEcCtD
Etonogestrel—Alopecia—Timolol—glaucoma	0.000384	0.000627	CcSEcCtD
Etonogestrel—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000381	0.0102	CbGpPWpGaD
Etonogestrel—Mental disorder—Timolol—glaucoma	0.00038	0.000621	CcSEcCtD
Etonogestrel—Dizziness—Dorzolamide—glaucoma	0.00038	0.000621	CcSEcCtD
Etonogestrel—Rash—Brimonidine—glaucoma	0.000379	0.00062	CcSEcCtD
Etonogestrel—Dermatitis—Brimonidine—glaucoma	0.000379	0.000619	CcSEcCtD
Etonogestrel—Dizziness—Travoprost—glaucoma	0.000378	0.000618	CcSEcCtD
Etonogestrel—Malnutrition—Timolol—glaucoma	0.000378	0.000617	CcSEcCtD
Etonogestrel—Erythema—Timolol—glaucoma	0.000378	0.000617	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—SOD1—glaucoma	0.000378	0.0101	CbGpPWpGaD
Etonogestrel—Oedema—Betaxolol—glaucoma	0.000378	0.000617	CcSEcCtD
Etonogestrel—Headache—Brimonidine—glaucoma	0.000377	0.000616	CcSEcCtD
Etonogestrel—Decreased appetite—Clonidine—glaucoma	0.000377	0.000616	CcSEcCtD
Etonogestrel—ESR1—Nuclear Receptor transcription pathway—NR3C1—glaucoma	0.000376	0.0101	CbGpPWpGaD
Etonogestrel—Infection—Betaxolol—glaucoma	0.000375	0.000613	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Clonidine—glaucoma	0.000374	0.000611	CcSEcCtD
Etonogestrel—Fatigue—Clonidine—glaucoma	0.000374	0.000611	CcSEcCtD
Etonogestrel—Dizziness—Brinzolamide—glaucoma	0.000374	0.00061	CcSEcCtD
Etonogestrel—Nausea—Acetazolamide—glaucoma	0.000372	0.000608	CcSEcCtD
Etonogestrel—Diarrhoea—Pilocarpine—glaucoma	0.000372	0.000607	CcSEcCtD
Etonogestrel—Tension—Timolol—glaucoma	0.000371	0.000606	CcSEcCtD
Etonogestrel—Constipation—Clonidine—glaucoma	0.000371	0.000606	CcSEcCtD
Etonogestrel—Pain—Clonidine—glaucoma	0.000371	0.000606	CcSEcCtD
Etonogestrel—Nervous system disorder—Betaxolol—glaucoma	0.00037	0.000605	CcSEcCtD
Etonogestrel—Nervousness—Timolol—glaucoma	0.000367	0.000599	CcSEcCtD
Etonogestrel—Skin disorder—Betaxolol—glaucoma	0.000367	0.000599	CcSEcCtD
Etonogestrel—Vomiting—Dorzolamide—glaucoma	0.000365	0.000597	CcSEcCtD
Etonogestrel—Rash—Dorzolamide—glaucoma	0.000362	0.000592	CcSEcCtD
Etonogestrel—Dermatitis—Dorzolamide—glaucoma	0.000362	0.000591	CcSEcCtD
Etonogestrel—Rash—Travoprost—glaucoma	0.000361	0.000589	CcSEcCtD
Etonogestrel—Dermatitis—Travoprost—glaucoma	0.00036	0.000589	CcSEcCtD
Etonogestrel—Headache—Dorzolamide—glaucoma	0.00036	0.000588	CcSEcCtD
Etonogestrel—Anorexia—Betaxolol—glaucoma	0.00036	0.000588	CcSEcCtD
Etonogestrel—Vomiting—Brinzolamide—glaucoma	0.000359	0.000587	CcSEcCtD
Etonogestrel—Dizziness—Pilocarpine—glaucoma	0.000359	0.000586	CcSEcCtD
Etonogestrel—Headache—Travoprost—glaucoma	0.000358	0.000585	CcSEcCtD
Etonogestrel—Nausea—Brimonidine—glaucoma	0.000357	0.000584	CcSEcCtD
Etonogestrel—Feeling abnormal—Clonidine—glaucoma	0.000357	0.000584	CcSEcCtD
Etonogestrel—Rash—Brinzolamide—glaucoma	0.000356	0.000582	CcSEcCtD
Etonogestrel—Dermatitis—Brinzolamide—glaucoma	0.000356	0.000581	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Clonidine—glaucoma	0.000355	0.000579	CcSEcCtD
Etonogestrel—Headache—Brinzolamide—glaucoma	0.000354	0.000578	CcSEcCtD
Etonogestrel—Angioedema—Timolol—glaucoma	0.000345	0.000564	CcSEcCtD
Etonogestrel—Vomiting—Pilocarpine—glaucoma	0.000345	0.000564	CcSEcCtD
Etonogestrel—Urticaria—Clonidine—glaucoma	0.000345	0.000563	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000344	0.000562	CcSEcCtD
Etonogestrel—Abdominal pain—Clonidine—glaucoma	0.000343	0.00056	CcSEcCtD
Etonogestrel—Body temperature increased—Clonidine—glaucoma	0.000343	0.00056	CcSEcCtD
Etonogestrel—Rash—Pilocarpine—glaucoma	0.000342	0.000559	CcSEcCtD
Etonogestrel—Dermatitis—Pilocarpine—glaucoma	0.000342	0.000559	CcSEcCtD
Etonogestrel—Insomnia—Betaxolol—glaucoma	0.000341	0.000558	CcSEcCtD
Etonogestrel—Nausea—Dorzolamide—glaucoma	0.000341	0.000558	CcSEcCtD
Etonogestrel—Headache—Pilocarpine—glaucoma	0.00034	0.000556	CcSEcCtD
Etonogestrel—Nausea—Travoprost—glaucoma	0.00034	0.000555	CcSEcCtD
Etonogestrel—Paraesthesia—Betaxolol—glaucoma	0.000339	0.000554	CcSEcCtD
Etonogestrel—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000337	0.00904	CbGpPWpGaD
Etonogestrel—Nausea—Brinzolamide—glaucoma	0.000336	0.000548	CcSEcCtD
Etonogestrel—Dyspepsia—Betaxolol—glaucoma	0.000332	0.000543	CcSEcCtD
Etonogestrel—Cough—Timolol—glaucoma	0.00033	0.000539	CcSEcCtD
Etonogestrel—Decreased appetite—Betaxolol—glaucoma	0.000328	0.000536	CcSEcCtD
Etonogestrel—Hypertension—Timolol—glaucoma	0.000326	0.000533	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Betaxolol—glaucoma	0.000326	0.000532	CcSEcCtD
Etonogestrel—Fatigue—Betaxolol—glaucoma	0.000326	0.000532	CcSEcCtD
Etonogestrel—Pain—Betaxolol—glaucoma	0.000323	0.000527	CcSEcCtD
Etonogestrel—Constipation—Betaxolol—glaucoma	0.000323	0.000527	CcSEcCtD
Etonogestrel—Nausea—Pilocarpine—glaucoma	0.000323	0.000527	CcSEcCtD
Etonogestrel—Arthralgia—Timolol—glaucoma	0.000322	0.000525	CcSEcCtD
Etonogestrel—Myalgia—Timolol—glaucoma	0.000322	0.000525	CcSEcCtD
Etonogestrel—Anxiety—Timolol—glaucoma	0.000321	0.000524	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.00032	0.000522	CcSEcCtD
Etonogestrel—Hypersensitivity—Clonidine—glaucoma	0.00032	0.000522	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—EDN1—glaucoma	0.000319	0.00856	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP2—glaucoma	0.000318	0.00855	CbGpPWpGaD
Etonogestrel—Discomfort—Timolol—glaucoma	0.000318	0.000519	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—MMP2—glaucoma	0.000312	0.00838	CbGpPWpGaD
Etonogestrel—Asthenia—Clonidine—glaucoma	0.000311	0.000508	CcSEcCtD
Etonogestrel—Feeling abnormal—Betaxolol—glaucoma	0.000311	0.000508	CcSEcCtD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—glaucoma	0.00031	0.00831	CbGpPWpGaD
Etonogestrel—Anaphylactic shock—Timolol—glaucoma	0.000308	0.000504	CcSEcCtD
Etonogestrel—Oedema—Timolol—glaucoma	0.000308	0.000504	CcSEcCtD
Etonogestrel—Pruritus—Clonidine—glaucoma	0.000307	0.000501	CcSEcCtD
Etonogestrel—Infection—Timolol—glaucoma	0.000306	0.0005	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—BCL2L1—glaucoma	0.000306	0.00821	CbGpPWpGaD
Etonogestrel—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000305	0.00818	CbGpPWpGaD
Etonogestrel—Nervous system disorder—Timolol—glaucoma	0.000302	0.000494	CcSEcCtD
Etonogestrel—Urticaria—Betaxolol—glaucoma	0.0003	0.00049	CcSEcCtD
Etonogestrel—Skin disorder—Timolol—glaucoma	0.0003	0.000489	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—C3—glaucoma	0.000299	0.00804	CbGpPWpGaD
Etonogestrel—Body temperature increased—Betaxolol—glaucoma	0.000298	0.000487	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—NOS3—glaucoma	0.000298	0.00801	CbGpPWpGaD
Etonogestrel—Diarrhoea—Clonidine—glaucoma	0.000297	0.000485	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN2B—glaucoma	0.000296	0.00794	CbGpPWpGaD
Etonogestrel—Anorexia—Timolol—glaucoma	0.000294	0.00048	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—NR3C1—glaucoma	0.000292	0.00783	CbGpPWpGaD
Etonogestrel—Dizziness—Clonidine—glaucoma	0.000287	0.000468	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—CDKN2A—glaucoma	0.000286	0.00768	CbGpPWpGaD
Etonogestrel—Musculoskeletal discomfort—Timolol—glaucoma	0.000281	0.000459	CcSEcCtD
Etonogestrel—Insomnia—Timolol—glaucoma	0.000279	0.000456	CcSEcCtD
Etonogestrel—Hypersensitivity—Betaxolol—glaucoma	0.000278	0.000454	CcSEcCtD
Etonogestrel—Paraesthesia—Timolol—glaucoma	0.000277	0.000452	CcSEcCtD
Etonogestrel—Vomiting—Clonidine—glaucoma	0.000276	0.00045	CcSEcCtD
Etonogestrel—Somnolence—Timolol—glaucoma	0.000274	0.000448	CcSEcCtD
Etonogestrel—Rash—Clonidine—glaucoma	0.000273	0.000447	CcSEcCtD
Etonogestrel—Dermatitis—Clonidine—glaucoma	0.000273	0.000446	CcSEcCtD
Etonogestrel—Headache—Clonidine—glaucoma	0.000272	0.000444	CcSEcCtD
Etonogestrel—Dyspepsia—Timolol—glaucoma	0.000272	0.000443	CcSEcCtD
Etonogestrel—Asthenia—Betaxolol—glaucoma	0.000271	0.000442	CcSEcCtD
Etonogestrel—Decreased appetite—Timolol—glaucoma	0.000268	0.000438	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—MMP1—glaucoma	0.000268	0.0072	CbGpPWpGaD
Etonogestrel—Pruritus—Betaxolol—glaucoma	0.000267	0.000436	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Timolol—glaucoma	0.000266	0.000435	CcSEcCtD
Etonogestrel—Fatigue—Timolol—glaucoma	0.000266	0.000434	CcSEcCtD
Etonogestrel—Pain—Timolol—glaucoma	0.000264	0.000431	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—NR3C1—glaucoma	0.00026	0.00697	CbGpPWpGaD
Etonogestrel—Diarrhoea—Betaxolol—glaucoma	0.000258	0.000422	CcSEcCtD
Etonogestrel—Nausea—Clonidine—glaucoma	0.000258	0.000421	CcSEcCtD
Etonogestrel—Feeling abnormal—Timolol—glaucoma	0.000254	0.000415	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—BCL2L1—glaucoma	0.000252	0.00678	CbGpPWpGaD
Etonogestrel—Gastrointestinal pain—Timolol—glaucoma	0.000252	0.000412	CcSEcCtD
Etonogestrel—Dizziness—Betaxolol—glaucoma	0.00025	0.000408	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000249	0.00668	CbGpPWpGaD
Etonogestrel—Urticaria—Timolol—glaucoma	0.000245	0.0004	CcSEcCtD
Etonogestrel—ESR1—FOXA1 transcription factor network—CDKN1B—glaucoma	0.000244	0.00655	CbGpPWpGaD
Etonogestrel—Body temperature increased—Timolol—glaucoma	0.000244	0.000398	CcSEcCtD
Etonogestrel—Abdominal pain—Timolol—glaucoma	0.000244	0.000398	CcSEcCtD
Etonogestrel—Vomiting—Betaxolol—glaucoma	0.00024	0.000392	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP9—glaucoma	0.000239	0.00642	CbGpPWpGaD
Etonogestrel—Rash—Betaxolol—glaucoma	0.000238	0.000389	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—MMP2—glaucoma	0.000238	0.00639	CbGpPWpGaD
Etonogestrel—Dermatitis—Betaxolol—glaucoma	0.000238	0.000388	CcSEcCtD
Etonogestrel—Headache—Betaxolol—glaucoma	0.000237	0.000386	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000236	0.00632	CbGpPWpGaD
Etonogestrel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000229	0.00615	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—BAD—glaucoma	0.000229	0.00614	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Timolol—glaucoma	0.000227	0.000371	CcSEcCtD
Etonogestrel—Nausea—Betaxolol—glaucoma	0.000224	0.000366	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—BAD—glaucoma	0.000222	0.00595	CbGpPWpGaD
Etonogestrel—Asthenia—Timolol—glaucoma	0.000221	0.000361	CcSEcCtD
Etonogestrel—Pruritus—Timolol—glaucoma	0.000218	0.000356	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	0.000217	0.00582	CbGpPWpGaD
Etonogestrel—Diarrhoea—Timolol—glaucoma	0.000211	0.000345	CcSEcCtD
Etonogestrel—Dizziness—Timolol—glaucoma	0.000204	0.000333	CcSEcCtD
Etonogestrel—Vomiting—Timolol—glaucoma	0.000196	0.00032	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000196	0.00526	CbGpPWpGaD
Etonogestrel—Rash—Timolol—glaucoma	0.000194	0.000318	CcSEcCtD
Etonogestrel—Dermatitis—Timolol—glaucoma	0.000194	0.000317	CcSEcCtD
Etonogestrel—Headache—Timolol—glaucoma	0.000193	0.000316	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CDKN2A—glaucoma	0.00019	0.0051	CbGpPWpGaD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—glaucoma	0.000184	0.00495	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—NOS3—glaucoma	0.000184	0.00494	CbGpPWpGaD
Etonogestrel—Nausea—Timolol—glaucoma	0.000183	0.000299	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—LRP12—glaucoma	0.000182	0.0049	CbGpPWpGaD
Etonogestrel—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.00018	0.00483	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—CDKN1B—glaucoma	0.000172	0.00463	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—CDKN1B—glaucoma	0.000168	0.00452	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.000168	0.00451	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	0.000162	0.00434	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—TP53—glaucoma	0.000156	0.00419	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MMP9—glaucoma	0.000156	0.00419	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—CDKN1B—glaucoma	0.000154	0.00414	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	0.000149	0.004	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	0.000148	0.00397	CbGpPWpGaD
Etonogestrel—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000145	0.0039	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MMP1—glaucoma	0.000145	0.00389	CbGpPWpGaD
Etonogestrel—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000144	0.00385	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—BAD—glaucoma	0.000131	0.00351	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—BAD—glaucoma	0.00013	0.00349	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	0.000127	0.0034	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—OPN4—glaucoma	0.000126	0.0034	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—CDKN2B—glaucoma	0.000126	0.00338	CbGpPWpGaD
Etonogestrel—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000118	0.00317	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HEYL—glaucoma	0.000118	0.00316	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PTGFR—glaucoma	0.000114	0.00306	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—NR3C1—glaucoma	0.000111	0.00297	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	0.000108	0.00291	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—LRP12—glaucoma	0.000107	0.00288	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—glaucoma	0.000106	0.00284	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—CDKN1B—glaucoma	9.05e-05	0.00243	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—RPTOR—glaucoma	8.91e-05	0.00239	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NCK2—glaucoma	8.63e-05	0.00232	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	7.96e-05	0.00214	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTT1—glaucoma	7.86e-05	0.00211	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—glaucoma	7.57e-05	0.00203	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	7.54e-05	0.00202	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—OPN4—glaucoma	7.42e-05	0.00199	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—CDKN2B—glaucoma	7.4e-05	0.00199	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HDAC9—glaucoma	7.34e-05	0.00197	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HEYL—glaucoma	6.9e-05	0.00185	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PTGFR—glaucoma	6.68e-05	0.00179	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—NR3C1—glaucoma	6.49e-05	0.00174	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	6.27e-05	0.00168	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—CYP1B1—glaucoma	6.26e-05	0.00168	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	6.18e-05	0.00166	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—CDKN2B—glaucoma	6.07e-05	0.00163	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SMO—glaucoma	5.74e-05	0.00154	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—glaucoma	5.72e-05	0.00154	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CA5A—glaucoma	5.51e-05	0.00148	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NARFL—glaucoma	5.51e-05	0.00148	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	5.38e-05	0.00144	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—NR3C1—glaucoma	5.33e-05	0.00143	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NTRK2—glaucoma	5.25e-05	0.00141	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—RPTOR—glaucoma	5.23e-05	0.0014	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NCK2—glaucoma	5.07e-05	0.00136	CbGpPWpGaD
Etonogestrel—CYP3A4—Biological oxidations—GSTM1—glaucoma	5.01e-05	0.00134	CbGpPWpGaD
Etonogestrel—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	4.94e-05	0.00133	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	4.74e-05	0.00127	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NGFR—glaucoma	4.51e-05	0.00121	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HDAC9—glaucoma	4.31e-05	0.00116	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NTRK1—glaucoma	4.28e-05	0.00115	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN2B—glaucoma	3.95e-05	0.00106	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EDN1—glaucoma	3.79e-05	0.00102	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—CDKN2B—glaucoma	3.56e-05	0.000956	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NGF—glaucoma	3.48e-05	0.000934	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SMO—glaucoma	3.37e-05	0.000905	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—C3—glaucoma	3.31e-05	0.000888	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—NR3C1—glaucoma	3.13e-05	0.000839	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NTRK2—glaucoma	3.08e-05	0.000828	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—APOE—glaucoma	3.08e-05	0.000827	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CAV1—glaucoma	3.05e-05	0.000819	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FN1—glaucoma	2.9e-05	0.00078	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—BAD—glaucoma	2.87e-05	0.00077	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CA1—glaucoma	2.69e-05	0.000722	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NGFR—glaucoma	2.64e-05	0.00071	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CTSA—glaucoma	2.61e-05	0.0007	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NTRK1—glaucoma	2.51e-05	0.000675	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CA2—glaucoma	2.46e-05	0.000661	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN2B—glaucoma	2.32e-05	0.000622	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NOS3—glaucoma	2.31e-05	0.000619	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EDN1—glaucoma	2.22e-05	0.000597	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NGF—glaucoma	2.04e-05	0.000548	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CDKN1B—glaucoma	2e-05	0.000537	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—C3—glaucoma	1.94e-05	0.000521	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MMP9—glaucoma	1.85e-05	0.000497	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—APOE—glaucoma	1.81e-05	0.000485	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CAV1—glaucoma	1.79e-05	0.000481	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—TXN—glaucoma	1.73e-05	0.000465	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FN1—glaucoma	1.7e-05	0.000458	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—BAD—glaucoma	1.68e-05	0.000452	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—glaucoma	1.66e-05	0.000446	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NOS3—glaucoma	1.35e-05	0.000364	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTT1—glaucoma	1.34e-05	0.000361	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—glaucoma	1.26e-05	0.000337	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CDKN1B—glaucoma	1.17e-05	0.000315	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MMP9—glaucoma	1.09e-05	0.000292	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ABCA1—glaucoma	1.07e-05	0.000288	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CYP1B1—glaucoma	1.07e-05	0.000288	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—glaucoma	9.75e-06	0.000262	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—GSTM1—glaucoma	8.56e-06	0.00023	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—MTHFR—glaucoma	7.57e-06	0.000203	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—glaucoma	7.37e-06	0.000198	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—APOE—glaucoma	7.05e-06	0.000189	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—CAV1—glaucoma	6.98e-06	0.000187	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—NOS3—glaucoma	5.28e-06	0.000142	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PTGS2—glaucoma	4.83e-06	0.00013	CbGpPWpGaD
